Proteomics International is a medical technology company that specializes in proteomics, the study of proteins. The company has over 16 years of experience providing analytical services on a fee-for-service basis and has a strong research expertise in identifying new diagnostic protein biomarkers. Proteomics International has recently developed a predictive test for diabetic kidney disease called PromarkerD. This ground-breaking test is a promising advance in the field of personalized medicine.
Proteomics International's ticker is PIQ
The company's shares trade on the ASX stock exchange
They are based in Perth, Australia
There are 11-50 employees working at Proteomics International
It is https://www.proteomics.com.au/
Proteomics International is in the Healthcare sector
Proteomics International is in the Biotechnology industry
The following five companies are Proteomics International's industry peers: